Value of positron emission tomography in urological neoplasms. More form than substance?

被引：0
作者：
Mueller, J. [1 ]
Schrader, M. [1 ]
Schrader, A. J. [1 ]
Hoepfner, M. [2 ]
Zengerling, F. [1 ,2 ]
机构：
[1] Univ Ulm Klinikum, Klin Urol, D-89075 Ulm, Germany
[2] Charite, Inst Physiol, D-13353 Berlin, Germany
来源：
UROLOGE | 2012年 / 51卷 / 03期
关键词：
Positron emission tomography; Urological neoplasms; Primary diagnosis; Staging; Recurrence; RENAL-CELL CARCINOMA; LOCALIZED PROSTATE-CANCER; LYMPH-NODE METASTASES; PENILE CARCINOMA; C-11-CHOLINE PET/CT; BLADDER-CANCER; TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY; F-18-FDG PET/CT; RESIDUAL MASSES; HIGH-RISK;
D O I：
10.1007/s00120-012-2834-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Positron emission tomography/computed tomography (PET/CT) is widely used for imaging urological neoplasms. This overview should help the urologist actively involved in oncology to assess the value of PET or PET/CT in each tumor entity. Besides prostate, testicular, renal, and bladder cancer less common urological malignancies like penile carcinoma and retroperitoneal masses are discussed. Differences in using PET/CT for primary diagnosis, staging, or restaging are outlined separately. Appropriate indications for the use in clinical practice are cited.
引用
收藏
页码：331 / +
页数：8
相关论文
共 83 条
[1]  
Agrawal A, 2000, J CLIN ULTRASOUND, V28, P399, DOI 10.1002/1097-0096(200010)28:8<399::AID-JCU4>3.3.CO
[2]  
2-A
[3]   Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases:: a comparison with CT [J].
Aide, N ;
Cappele, O ;
Bottet, P ;
Bensadoun, H ;
Regeasse, A ;
Comoz, F ;
Sobrio, F ;
Bouvard, G ;
Agostini, D .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) :1236-1245
[4]   Positron emission tomography in the clinical staging of patients with stage I and II testicular germ cell tumors [J].
Albers, P ;
Bender, H ;
Yilmaz, H ;
Schoeneich, G ;
Biersack, HJ ;
Mueller, SC .
UROLOGY, 1999, 53 (04) :808-811
[5]   EAU Guidelines on Testicular Cancer: 2011 Update [J].
Albers, Peter ;
Albrecht, Walter ;
Algaba, Ferran ;
Bokemeyer, Carsten ;
Cohn-Cedermark, Gabriella ;
Fizazi, Karim ;
Horwich, Alan ;
Laguna, Maria Pilar .
EUROPEAN UROLOGY, 2011, 60 (02) :304-319
[6]   The growing teratoma syndrome:: results of therapy and long-term follow-up of 33 patients [J].
André, F ;
Fizazi, K ;
Culine, S ;
Droz, JP ;
Taupin, P ;
Lhommé, C ;
Terrier-Lacombe, MJ ;
Théodore, C .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1389-1394
[7]   SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010) [J].
Aparicio, Jorge ;
Sastre, Javier ;
Ramon Germa, Jose ;
Isla, Dolores .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08) :560-564
[8]   FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals [J].
Becherer, A ;
De Santis, M ;
Karanikas, G ;
Szabó, M ;
Bokemeyer, C ;
Dohmen, BM ;
Pont, J ;
Dudczak, R ;
Dittrich, C ;
Kletter, K .
EUROPEAN JOURNAL OF RADIOLOGY, 2005, 54 (02) :284-288
[9]   Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT:: a comparative study [J].
Beheshti, Mohsen ;
Vali, Reza ;
Waldenberger, Peter ;
Fitz, Friedrich ;
Nader, Michael ;
Loidl, Wolfgang ;
Broinger, Gabriele ;
Stoiber, Franz ;
Foglman, Ignac ;
Langsteger, Werner .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) :1766-1774
[10]   18F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients [J].
Beheshti, Mohsen ;
Imamovic, Larisa ;
Broinger, Gabriele ;
Vali, Reza ;
Waldenberger, Peter ;
Stoiber, Franz ;
Nader, Michael ;
Gruy, Bernhard ;
Janetschek, Guenter ;
Langsteger, Werner .
RADIOLOGY, 2010, 254 (03) :925-933
123456789